NCT03852316: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03852316 |
|---|---|
| Title | Pivotal Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) in Women |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 27, 2019 |
| Completion date | Dec. 2, 2019 |
| Required reporting date | Dec. 2, 2022, midnight |
| Actual reporting date | Nov. 24, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |